Citadel Advisors’s Prenetics Global Ltd Warrant PRENW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,771
Closed -$138 14531
2025
Q1
$138 Sell
12,771
-301,517
-96% -$3.56K ﹤0.01% 14324
2024
Q4
$2.45K Sell
314,288
-16,360
-5% -$183 ﹤0.01% 14081
2024
Q3
$3.31K Sell
330,648
-32,693
-9% -$376 ﹤0.01% 13666
2024
Q2
$5.05K Buy
363,341
+349,950
+2,613% +$3.15K ﹤0.01% 13433
2024
Q1
$139 Sell
13,391
-7,794
-37% -$62 ﹤0.01% 14414
2023
Q4
$316 Buy
21,185
+592
+3% +$9 ﹤0.01% 14061
2023
Q3
$1.08K Buy
+20,593
New +$1.21K ﹤0.01% 13921

Other funds holding PRENW

Citadel Advisors's PRENW Position: Q2 2025 in Review

Citadel Advisors sold out of Prenetics Global Ltd Warrant (PRENW) in Q2 2025, closing a stake of 12,771 shares — an estimated $138 sold.

Citadel Advisors first reported a position in PRENW in Q3 2023 and held it in 7 quarters. The position peaked at $5.05K in Q2 2024. 17 funds tracked by Wall St. Rank hold PRENW as of Q2 2025.

  • Citadel Advisors reported no remaining Prenetics Global Ltd Warrant position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,771 Prenetics Global Ltd Warrant shares in Q2 2025, an estimated $138.
  • Citadel Advisors first reported a position in Prenetics Global Ltd Warrant in Q3 2023 and held it in 7 quarters.
  • Citadel Advisors's Prenetics Global Ltd Warrant position peaked at $5.05K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held Prenetics Global Ltd Warrant as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.